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Abstract
Meis1, a conserved transcription factor of the TALE-homeodomain class, is expressed in a wide variety of tissues during
development. Its complex expression pattern is likely to be controlled by an equally complex regulatory landscape. Here we
have scanned the Meis1 locus for regulatory elements and found 13 non-coding regions, highly conserved between
humans and teleost fishes, that have enhancer activity in stable transgenic zebrafish lines. All these regions are syntenic in
most vertebrates. The composite expression of all these enhancer elements recapitulate most of Meis1 expression during
early embryogenesis, indicating they comprise a basic set of regulatory elements of the Meis1 gene. Using bioinformatic
tools, we identify a number of potential binding sites for transcription factors that are compatible with the regulation of
these enhancers. Specifically, HHc2:066650, which is expressed in the developing retina and optic tectum, harbors several
predicted Pax6 sites. Biochemical, functional and transgenic assays indicate that pax6 genes directly regulate HHc2:066650
activity.
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Introduction
Meis genes belong to the TALE-homeodomain class of
conserved transcription factors. Together with their Drosophila
homologue, homothorax (hth), they are known to be required for the
development of many organs in vertebrates and invertebrates
[1,2,3]. Molecularly, Meis proteins are known partners of PBX
family proteins, also TALE-homeodomain transcription factors
and, together with them, interact with region and organ-specific
transcription factors, such as Hox, MyoD or Pax proteins
[2,4,5,6]. The founding member of the family in vertebrates,
Meis1 (myeloid ecotropic insertion site 1, [7]), has also been found
miss-expressed in a number of tumor types, including acute
myeloid leukemia [8], lung adenocarcinoma tumors [9], neuro-
blastomas [10,11,12], ovarian carcinomas [13] and nephroblasto-
mas [14].
Part of the pleiotropic developmental roles of Meis genes reside
in their complex and dynamic expression patterns. In zebrafish,
early meis1 expression is detected in the developing eye, and in the
midbrain and hindbrain regions. Later on, meis1 expression is
found in the ciliary marginal zone of the eye, optic tectum,
forebrain (presumably olfactory bulb) and branchial arches
[15,16]. In other vertebrates, Meis1 has been also detected in
the somites and proximal fore- and hind-limbs at different
developmental stages, as well as in the developing haematopoietic
system and the pancreas [17,18,19]. This complex expression
profile is likely to be controlled by an equally complex regulatory
landscape. However, very few studies have been carried out on the
transcriptional regulation of Meis genes [20]. In order to start
unraveling this complex regulation, we have set to identify cis-
regulatory elements (CREs) of the meis1 gene. First, we have used a
criterion of synteny and evolutionary conservation [21] to extract
non-coding DNA sequences from the meis1 locus conserved from
human to fish. This approach has been shown to be useful in CRE
identification [22]. Second, we have tested the enhancer potential
of these human sequences in vivo using zebrafish transgenesis. This
analysis has allowed us to find CREs containing transcriptional
enhancer activity with different degrees of tissue-specificity.
Finally, we have tried to identify potential trans-regulators of the
identified meis1 enhancers, using bioinformatics and gene expres-
sion data information. In all, this paper presents a first attempt at
unraveling the transcriptional regulatory complexity of the
vertebrate Meis1 locus, identifying a number of tissue-specific
CREs and predicting new potential regulators of Meis1 CREs.
Materials and Methods
Animal care
Zebrafish (Danio rerio) were maintained in our breeding colony
according to standard procedures (http://zfin.org). Embryos used
for Tol2-mediated transgenesis were obtained from the wild-type
AB/Tuebingen (AB/TU) zebrafish strain. Potential transgenic
founders were out-crossed to a TUP strain. Fertilized eggs were
kept at 28uC in E3 medium with 0.003% 1-phenyl-2-thiourea to
prevent pigmentation and were staged according to Kimmel et al.
[23].
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Candidate region selection criteria
Human sequences (genome release: hg18) were extracted from
those with at least 75% identity to mouse (genome release: mm8)
and at least 100 bp long. We removed the human-mouse
conserved elements that overlapped with gene annotations, human
mRNAs or repeats. The remaining human-mouse conserved non-
coding elements were clustered if they were 3 Kb or closer from
each other. We then checked if the clustered region had human-
chicken (genome release: galGal2), human-frog (genome release:
xenTro2) and human-zebrafish (genome release: danRer5)
conservation (at least 70% identity to human and at least 50 bp
long). In order to call a region as highly conserved non-coding
region (HCNR), we demanded that the clustered human-mouse
region overlapped with the respective conserved elements from all
the other species (chicken, frog and zebrafish). We extended the
HCNR 150 bp on both sides and looked for primers between 18
and 27 bp in those flanking regions (Table 1).
ZED-HCNR Collection
Human HCNR fragments where PCR-amplified using HiFi
Taq polymerase (Roche, Manheim, Germany) using standard
procedures. PCR products were cloned into the pCR8/GW/
TOPO vector (Invitrogen, Pasadena, USA). HCNR-containing
clones were recombined into the Zebrafish Enhancer Detection
(ZED) shuttle transgenesis vector [24]. Briefly, ZED contains two
modules flanked by Medaka (Oryza latipes) TOL2 transposase
target sites, enabling efficient transgenesis, as previously described
[25]. The first module contains the minimal GATA promoter
driving the expression of the enhanced green fluorescent protein
(GFP). All HCNRs were cloned upstream of this module using the
Gateway system (Invitrogen, Pasadena, USA). Two strong
insulators, which reduce the potential influence of the regulatory
elements that may be present in the vicinity of the integration sites,
flank this reporter cassette. The second module contains the
cardiac actin promoter driving the expression of the red
fluorescent protein (RFP), which serves as a positive control for
transgenesis in F0 and F1 embryos [24].
Selection of enhancer-containing HCNRs candidates
One-cell stage embryos were injected with 3–5 nl of a solution
containing 25 ng/ml of each construct and 25 ng/ml of TOL2
mRNA. A minimum of 300 embryos were injected per
experiment. Embryos where then incubated at 28uC as previously
described. GFP expression was evaluated 24, 48 and 72 hours
post-fertilization. Whenever GFP was observed, the HCNR tested
was considered as a potential candidate and embryos were selected
and raised to sexual maturity to be analyzed in F1. Both somites
and heart expression of RFP were used as positive control for
transgenesis and served to discard any HCNR without enhancer
activity. For high-resolution pictures a F-View black/white digital
camera coupled to a WD70 Nikon camera was used. Adobe
Photoshop was used to adjust bright and contrast.
Enhancer mutational assays
Mutation of the potential Pax6 binding sites was performed
using site-directed PCR-based mutagenesis over the pCR8 TOPO
containing the HHc2:066650 HCNR using the following muta-
genic oligos (59-39): Mut1F: CATAAATCTGTCTAACCGCA-
CATTT CTACACTAACCTGC, Mut1R: GCAGGTTAGTG-
TAGAAATGTGCGGTTAGAC AGATTTATG and Mut2F:
CTTGCTTGTGTCTCTGATTATAAAAATCACTGCT GA-
GGCC, Mut2R: GGCCTCAGCAGTGATTTTTATAATCA-
GAGACACAAG CAAG. The resulting construct was recom-
bined into the ZED vector. Upon injection, mosaic embryos were
selected according to the presence of RFP expression in the
somites, which served as an injection control. This selection was
made double blind by a different operator. Embryos were then
dechorionated and photographed using identical exposures. The
eye GFP expression for each embryo was normalized with its
somite RFP expression.
Whole-mount in situ hybridization
Embryos were raised at 28uC until fixed in 4% paraformalde-
hyde in PBS. Whole-mount in situ hybridization was performed as
previously described [26] using a digoxigenin-labeled anti-gfp
probe. For staining, anti-digoxigenin, an alkaline-phosphatase
Table 1. Human highly conserved non-coding regions
assayed for enhancer activity.
Region (Hg18) Construct name G0 GFP activity
chr2:65915131–65916370 HHc2:065915 YES
chr2:65944793–65946456 HHc2:065944 YES
chr2:65946418–65947702 HHc2:066515 n.d.
chr2:66363945–66365004 HHc2:066523 n.d.
chr2:66515157–66516033 HHc2:066543 YES
chr2:66523076–66524718 HHc2:066588 YES
chr2:66541547–66543530 HHc2:066589 YES
chr2:66543660–66544441 HHc2:066603 YES
chr2:66549771–66550550 HHc2:066617 YES
chr2:66588227–66589754 HHc2:066628 YES
chr2:66589737–66591000 HHc2:066629 n.d.
chr2:66628254–66628945 HHc2:066650 YES
chr2:66635244–66637062 HHc2:066659 YES
chr2:67361651–67363128 HHc2:066769 n.d.
chr2:66649442–66651672 HHc2:066775 YES
chr2:66651589–66653505 HHc2:067135 YES
chr2:66654727–66656625 HHc2:067156 YES
chr2:66658870–66660479 HHc2:067347 YES
chr2:66768926–66770178 HHc2:067361 YES
chr2:66775251–66777554 HHc2:067641 YES
chr2:67075335–67076935 HHc2:066104 YES
chr2:67134578–67136311 HHc2:066522 YES
chr2:67155556–67157246 HHc2:066569 YES
chr2:67316077–67317518 HHc2:066644 YES
chr2:67347336–67349242 HHc2:066683 YES
chr2:67361651–67363128 HHc2:066719 n.d.
chr2:67398590–67400452 HHc2:066758 n.d.
chr2:67641486–67643007 HHc2:066780 YES
chr2:67934055–67936018 HHc2:067044 n.d.
chr2:66103519–66104070 HHc2:067086 n.d.
chr2:66264836–66265369 HHc2:067288 n.d.
chr2:66442170–66442486 HHc2:067353 n.d.
chr2:66443231–66443891 HHc2:067289 n.d.
chr2:66522162–66522381 HHc2:067353 n.d.
Annotation of the regions corresponding to the human Hg18, that were
amplified by PCR and assayed for enhancer activity using the ZED vector. (n.d:
not detected).
doi:10.1371/journal.pone.0033617.t001
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conjugated antibody followed by NBT/BCIP was used. meis1 ISH
was performed as previously described [27].
Chromatin immunoprecipitation
For immunopreciptation assays we used a c-myc-tagged Pax6
protein, produced by fusing a c-Myc epitope to the 59 end of Oryza
latipes Pax6 full length open reading frame (Genebank accession
number CAA04395.1) (L. Beccari and P. Bovolenta, unpublished
results). One-cell stage embryos were injected with 100 pg of a
Pax6::Myc capped mRNA and incubated for 24 hpf before fixation
with 1.85% formaldehyde. Nuclei were further isolated prior to
sonication using Bioruptor (Diagenoder, Belgium). Lysates were
incubated with monoclonal anti-Myc (9E10, Babco#MMS150R-
500) conjugated with Magnetic Protein-G Dynabeads (Invitrogen,
Norway). DNA was purified from both input lysates and
immunoprecipitated samples and analyzed using using real time
qPCR. Oligos used were zHHc2:066650F: TGCCTTTGCCAT-
TAGTAATCC and zHHc2:066650R: CAGCCAACACATAGC-
CACAC. Amplifications were normalized according to a random
region from the zebrafish genome ControlF: AACAGCTACCGG-
TAATAAACT and ControlR: AGGAAACACTGCCAAATAA
GC.
Chromatin conformation capture (3C) assays
3C assays were performed according to standard procedures using
whole zebrafish embryos at 24 hpf [28]. Zebrafish BAC CH211-
216I21 spanning 214 kb covering the region of interest, was used
for normalization. Oligos were designed using Primer3 software
pointing towards the selected HindIII genomic restriction sites.
Downstream 3C_control: GGCTTAGCATCTTGTCAATGC,
Upstream 3C_control: TCGAAGACAACTGTCAGCTTTG, the
zHHc2:066650: TAACATGGCCAGAAATG TGC, promoter
anchor: AATGCCACTATCACTGCAAATG.
Web resources
For representation and non-coding conservation analysis of the
meis1 locus, we used the VISTA browser, taking as a reference
the human hg18 genome release [29] (http://pipeline.lbl.gov/
cgi-bin/gateway2). Synteny blocks were extracted from http://
ecrbrowser.dcode.org/ [30]. For comparative potential transcrip-
tion factor binding sites, the Consite Web Resource was used,
using the positional weight matrixes loaded from JASPAR [31]
(http://asp.ii.uib.no:8090/cgi-bin/CONSITE/consite/). Anno-
tated expression patterns of different transcription factors were
obtained from ZFIN (http://zfin.org).
Results
meis1 HCNRs are enriched in tissue-specific enhancers
Analysis of the genomic region surrounding the human meis1
transcriptional unit identifies a genomic desert of <1.5 Mb on
chromosome 2 between SPRED2 and ETAA1 genes. This region
has preserved its syntenic organization since the last common
ancestor of teleost fishes and humans (Figure S1), suggesting that
the large non-coding region surrounding the meis1 transcriptional
unit have been maintained as a large regulatory domain. Although
this vast area represents just <0.7% of human chromosome 2, it
contains 18% of all HCNRs present on this chromosome. This
HCNR enrichment has been previously shown to be characteristic
of developmental genes, and has been suggested to be associated to
their complex spatiotemporal expression patterns [22,32–36].
Using our own selection criteria (see methods for a detailed
description) together with the visual inspection of previously
annotated HCNRs via the VISTA browser [37,38], we selected a
total of 34 HCNRs present in the human meis1 locus (Hg18,
chr2:065.893.545–067.353.996) that exhibited a high degree of
conservation among vertebrates. These regions were amplified
from human DNA and assayed for enhancer activity using
transgenesis in zebrafish. Upon an initial evaluation at 24 and
48 hours post fertilization (hpf) in injected (mosaic) embryos, we
detected GFP activity in 65% (22 out of 34; Table 1) of the assayed
HCNRs, a surprisingly high proportion of the sequences tested.
Mosaic embryos injected with these constructs were raised to
sexual maturity and their progeny screened for stable transgenic
lines.
Upon outcrossing, we found reporter cassette transmission in
offsprings for 19 HCNRs, clearly detected by the somites-specific
expression of the transgenesis reporter control (RFP). GFP
expression patterns of stable transgenic lines are summarized in
table 2. Thirteen HCNRs out of the nineteen (68%) exhibited clear
enhancer activity when compared to stable lines carrying just the
empty backbone (Figure 1) [39,40]. Among them, 9 HCNRs
exhibited tissue-specific enhancer activity, consistently shared by all
the lines (no. of founders $3) established for each of them, as
illustrated in Figure 2 (for a full annotation see Figure S2). As
previously described, meis1 is expressed in the segmental plate,
midbrain, hindbrain and the eye field at 12 hpf. At 24 hpf meis1 can
be also detected in the somites and the spinal chord while the
expression in the hindbrain turns more intense in the rhombomeres.
At this stage meis1 eye expression is restricted to the retina, the
expression in the somites decays while appearing in novel territories
such as the olfactory bulb and the optic tectum. Finally, at 48 hpf,
branchial arches and pronephric ducts also start expressing meis1
[16]. As illustrated in Figure 2, several HCNRs drive the expression
to different territories of the central nervous system. HHc2:065944
shows expression in the rhombomeres, while HHc2:066543 show
expression in the telencephalon (presumable olfactory bulb). Both
HHc2:066628 and HHc2:066644 drive the expression of the GFP
to the spinal chord. HHc2:066543 together with HHc2:067135
exhibit also weak expression in some particular hindbrain cells. The
overlap between meis1 endogenous pattern and those driven by the
different HCNRs was particularly evident for HHc2:066650 (retina,
tectum and neural crest derivatives) and HHc2:066644 (hindbrain,
neural tube and branchial arches). Therefore, the HCNRs with
enhancer activity are expressed in domains of the expression pattern
of meis1 (Figure 2, panel B), except in somites, as no somite-specific
enhancers were detected among the different HCNRs assayed. The
only exception to this general rule was observed for HHc2:066522,
which drives GFP expression to the midbrain/hindbrain boundary,
a territory where meis1 is not expressed. This ectopic expression
could be explained if some important regulatory sequences were not
included in the cloned fragment.
For other HCNRs, patterns of GFP expression were non-
overlapping among the founder lines established for each of them
(HHc2:066683, HHc2:066104 or HHc2:065915). This suggested
that these HCNRs were still able to recruit basic transcriptional
machinery out of their genomic context, but lacked a clear tissue-
specific activity. A full description of the patterns obtained can be
found in (Figure S2). The remaining 6 HCNRs showed somite
RFP expression but no GFP, and were therefore considered false
positives. For the remaining constructs no transgene transmission
was obtained.
Exploring potential regulators upstream of mies1 taking
advantage of tissue-specific HCNRs
Human HCNR sequences showing enhancer activity were
analyzed in silico for potential transcription factors binding sites
using JASPAR positional weigh matrixes (PWM) at the Consite
Meis1 Enhancers
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Figure 1. Distribution of the human conserved non-coding regions showing enhancer activity in transgenic Zebrafish. Vista browser
representation of the genomic region surrounding the human MEIS1 gene (chr2:065.893.545–067.353.996), using Hg18 human genome as reference.
Conservation is represented as pink peaks. Conserved non-coding elements (CNEs) with confirmed enhancer activity in stable transgenic zebrafish
lines are marked as vertical bars.
doi:10.1371/journal.pone.0033617.g001
Table 2. Enhancer activity displayed by the HCNRs in stable transgenesis at 24–48 hpf.
Construct
Founders
(n)
Enhancer
activity in F1 Forebrain Midbrain Hindbrain Eye
Branchial
arches
Neural
tube
Otic
vesicle Notes
HHc2:065915 6 + 2 1 1 2 - 1 2 Booster: Larynx, lens and hatching gland
HHc2:065944 5 +++ - - 5 - - 1 - When hindbrain also Rhombomere
HHc2:066541 5 2 - - - 1 - - 1
HHc2:066543 5 + 3 - 2 - - 1 2
HHc2:066588 6 +++ 3 - 2 1 2 - 1 Notochord, n = 1
HHc2:066628 5 ++ 3 1 4 3 - 2 - Fins: n = 1
HHc2:066650 4 +++ 3 2 3 2 - 1 -
HHc2:066659 7 +++ 2 - 3 - - 1 2
HHc2:066775 3 2 - - - - - - -
HHc2:067135 4 + 1 - 3 - - - -
HHc2:067347 3 +++ 1 - 3 - - - -
HHc2:067361 3 2 - - - - - - -
HHc2:067641 2 2 - - - - - - -
HHc2:066104 5 ++ 1 - 1 2 1 1 3 When eye also lens
HHc2:066522 5 +++ - 4 - - - - - Midbrain/hindbrain boundary
HHc2:066569 4 2 - - - - - . -
HHc2:066644 5 + - - 2 - 1 2 1
HHc2:066683 6 +++ 1 1 2 1 - 2 - Muscles at 24 hpf; n = 1
HHc2:066780 3 2 - - - - - - -
Table summarizing the GFP expression patterns and the enhancer activity found in the study. The ‘‘+’’ symbol in the enhancer activity column symbolizes the strength
of the expression patterns according to GFP expression levels regardless of the similarity among founders. The ‘‘2’’ symbol represents the absence of activity. Columns
4–11 refer to the number of founders showing GFP expression on each territory. A CNE was classified as ‘‘negative’’ if at least two founder lines did not show any GFP
expression. To annotate the expression pattern of any positive CNE, at least three stable transgenic lines were analysed. ‘‘Booster’’ refers to HCNRs that, when in
different stable lines, drive expression in very different patterns, as if boosting the position effects.
doi:10.1371/journal.pone.0033617.t002
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Web Resource (Table S1). This analysis provided a wide range
of potential direct meis1 upstream regulators. Although extreme-
ly sensitive, this approach is particularly prone to detect false
positives. To increase the reliability of these predictions, we
applied two additional filters. First, we selected those sites with
highest PWM scores (in the first quartile). Second, of those, we
identified the sites conserved between human and zebrafish,
with a conservation cut-off above 75%, according to the analysis
carried out using the CONSITE web resource. Then, we
analyzed the expression of each of the potential trans-regulators
using the in situ RNA expression data available at ZFIN (www.
zfin.org) and selected those whose expression overlapped with
the HCNR-driven GFP expression. Of these potential direct
regulators, runx1, pbx family members and pax6 had been
previously shown to interact with meis1 [2,4,5,6], although none
of these studies provided evidence for them acting as direct
Figure 2. Enhancer activities from the HCNRs recapitulate endogenous meis1 expression pattern. A) Dorsal and lateral views of a
representative founder illustrate the expression pattern of each HCNR. B) Picture of a meis1 in situ hybridization of a 30 hpf embryo illustrates the
different expression territories. A color-based schema of a zebrafish embryo highlights the different domains where GFP expression was found during
the study. C) Diagrams of patterns of expressions of highly penetrant enhancers (boxed in red) and of non-tissue specific enhancers (boxed in blue).
In each diagram, the number of founder lines showing expression in each particular body structure is represented by the red lines. For example, of
three lines of HHc2:066543, all three showed forebrain expression, and additionally, two of them drove expression in the hindbrain while the
remaining one in the neural tube. In situ hybridization picture is from ZFIN [16].
doi:10.1371/journal.pone.0033617.g002
Meis1 Enhancers
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upstream regulators of meis1. Interestingly, we noted that
HCNR HHc2:066650 expressed GFP starting around 12 hpf
(Figure 3A), when it is detected in the forming eye vesicles,
midbrain and hindbrain, and, in later embryos, in the retina and
tectum. This expression pattern coincides with that of meis1 in
the anterior neural tube [15,16]. Interestingly, Pax6 genes are
expressed in the retina and optic tectum in a number of
vertebrates [41–43]. Moreover, when orthologous sequences
from both human and zebrafish were compared, one of the two
best-fitting Pax6 potential binding sites (Figure 3D) mapped to
the same relative position in the enhancer, within a microisland
of ultraconservation inside the HCNR (Figure 3E). To test the
requirement of Pax6 for HHc2:066650 enhancer activity in
zebrafish, we injected morpholinos against the two zebrafish
paralogues, pax6a and pax6b, alone or in combination, in
HHc2:066650-GFP one-cell embryos. As previously described,
pax6a and pax6b morphants showed microphthalmia (Figure S3)
[44]. When GFP expression was analyzed in the eye primordia
of MOpax6a or MOpax6b-injected HHc2:066650-GFP embry-
os, a strong decrease in the number of GFP-positive cells in the
retina (normalized for total retinal area) (Figure 4A, Figure S4)
was detected. We also noted a decreased expression in the
prospective optic tectum. These results indicated that Pax6 gene
activity is required for HHc2:066650-enhancer activity.
Figure 3. HCNR sequence analysis suggests novel meis1 upstream regulators. (A) meis1 transcription, detected by in situ hybridization
(upper panel) compared to GFP expression, driven by the HHc2:066650-GFP transgenic line (lower panel) at 12 (left), 24 (middle) and 30 hpf (right).
Side views are shown. HHc2:066650 drives GFP expression in the eye primordium, the early hindbrain, the retina, the optic tectum and the olfactory
bulb, which are meis1 expression domains. B) The analysis of the potential binding sites predicted by Jaspar highlights the presence of three potential
Pax6 sites. Two of these sites contain a high degree of similarity with the consensus. (C) Pax6_Binding_Site1 also mapped to a microisland of
ultraconservation when human and zebrafish orthologous regions were aligned.
doi:10.1371/journal.pone.0033617.g003
Meis1 Enhancers
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33617
Figure 4. Pax6 regulates the enhancer activity of HHc2:066650. A) Representative pictures of transgenic zebrafish embryos at 24 and 48 hpf,
corresponding to HHc2:066650 F2 offspring injected with MOpaxA, MOpaxB, or a mixture of both. The red arrow points to the retina, where a strong
decrease in the GFP levels is observed after morpholino treatment. A control mopholino-injected individual is shown for comparison. B)
Representative mosaic embryos injected with HHc2:066650 construct with/without the two candidate Pax6 binding sites. Both the GFP and RFP
channels are included. The boxed region is magnified on the right. The dashed circle delineates the eye. (C) GFP expression was measured in the eye
(area marked by the dashed circle in (B)) of wild type and Dpax6_BS version of HHc2:066650 mosaic embryos (n = 9 and 11 embryos, respectively),
and normalized with their respective muscle RFP expression. Enhancer signal significantly decreased in the mutant version of HHc2:066650 (p = 0.018,
Mann Whitney test). The box plots contains a central rectangle, which spans from the first quartile to the third quartile. A segment inside the
rectangle shows the median and whiskers above and below the box show the locations of the minimum and maximum.
doi:10.1371/journal.pone.0033617.g004
Meis1 Enhancers
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Pax6 directly regulates retinal expression of a meis1 eye
enhancer
The results described so far suggested a direct regulation of
Pax6 on HHc2:066650. To test this point, we decided to mutate
the highest scoring Pax6 binding sites (Pax6_BS1 and 2) and to
compare the retinal GFP expression pattern driven by the control
and the mutated version of HHc2:066650. For this assay, we took
advantage of the high penetrance of the GFP expression driven by
HHc2:066650 in F0 (i.e. mosaic) embryos, where nearly 70% of
the injected embryos consistently showed a GFP expression
pattern comparable to that of the stable transgenic lines
(Figure 4B, upper panel). The two constructs (i.e. wild type and
DPax6_BS HHc2:066650) were injected and GFP signal was
quantified. Reporter expression was normalized against RFP
somite expression, which gave us a measure of the transformation
efficiency in each embryo. As illustrated in Figure 4, the signal in
DPax6_BS HHc2:066650 was reduced more than two-fold
compared to the levels driven by the wild type HCNR
(p = 0.018, Mann Whitney test). Even though these results do
not rule out the possibility that other Pax6 BSs are active in this
enhancer, they indicate that the two mutated BSs are required for
normal expression levels.
To test for actual Pax6 binding to HHc2:066650, we injected a
Myc-tagged version of Pax6 mRNA in one-celled zebrafish
embryos. Chromatin immunoprecipitation using an anti-Myc Ab
followed by quantitative amplification of the zebrafish
HHc2:066650 orthologous region showed a three-fold enrichment
of this CRE relative to input chromatin (Figure S5), supporting
direct binding of Pax6 to HHc2:066650. The pattern of expression
driven by HHc2:066650 is reminiscent of a subset of pattern
elements of the meis1 gene, strongly suggesting that it is indeed a
meis1 CRE. In order test whether zebrafish HHc2:066650
contacted the endogenous meis1 promoter, we designed a series
of 3C experiments. In these assays, the normalized 3C signal of
zebrafish HHc2:066650 was significantly higher than that of two
control regions mapping proximal and distal, respectively, to it
(Figure 5), which demonstrates an in vivo physical interaction
between this CRE and the meis1 promoter.
All results described in this section indicated that pax6 exerted a
direct regulation on a meis1 CRE. In order to test the relevance of
this pax6-meis1 interaction, we asked what effects the manipulation
pax6 levels would have on meis1 transcription. We evaluated the
effects on meis1 transcription by whole mount in situ hybridization
in pax6a, pax6b and pax6a+pax6b morphant embryos at 18 hpf, but
detected no obvious alterations in neither meis1 pattern nor levels.
Discussion
Here we present the first systematic scan for conserved cis-
regulatory regions governing the expression of the meis1 gene in
any vertebrate. Our functional analysis of the HCNRs found in
the meis1 locus reveals that a large proportion of these sequences
contain tissue-specific enhancers. These are active in many of the
tissues where meis1 itself is expressed at the stages analyzed,
including regions of the neural tube, retina, olfactory bulb and
branchial arches. Of note is that, even at these early stages, meis1
expression in the neural tube is composite, likely resulting from the
integration of many independent enhancers. It is also likely that
our screening method missed some HCNRs with enhancer activity
in small expression domains, since HCNRs were pre-screened for
GFP expression in F0. This is because of the mosaic nature of F0
expression, by which large expression domains are more likely to
be detected than small ones. This, together with the fact that
enhancers can also be found in non-coding DNA that is not
evolutionarily conserved [45,46] suggests that unraveling the
upstream regulatory cascades controlling meis1 expression will be
complicated due to the multiplicity of cis-regulatory elements.
However, the degree of concordance between the enhancer
expression territories found in our study and the endogenous meis1
expression suggests that our analysis has identified a significant
number of meis1 tissue-specific enhancers. In addition, synteny has
been found in the gene desert surrounding meis1 and these non-
coding regions show a high degree of conservation across
evolution. Altogether, this data allow us to propose that
orthologous sequences of these enhancers may also be meis1
enhancers with similar activity in other vertebrates. Thereby, these
HCNRs might comprise an evolutionarily conserved set of meis1
cis-regulatory regions.
From the regulatory point of view, we must highlight the
interesting behavior found among the different enhancer activities
Figure 5. Chromatin conformation assays measuring in vivo the relative interaction frequency between zHHc2:066650 and meis1
promoter. Relative interaction of the zebrafish HHc2:066650 orthologous region and the meis1 promoter, 70.8 Kb upstream of zHHc2:066650.
Interaction frequency was measured relative to two control regions: the first control maps 62 Kb upstream zHHc2:066650, while the second one lies
47.8 Kb downstream the enhancer. Interaction between meis1 promoter and zHHc2:066650 shows a 3-fold increase when compared to the controls.
Error bars represent the standard deviation of three independent measurements.
doi:10.1371/journal.pone.0033617.g005
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here reported. We observe HCNRs with different degrees of
enhancer penetrance, defined as the degree of similarity between
the different founders of the same HCNR. Some sequences drive
highly reproducible expression patterns (i.e. HHc2:065944,
HHc2:067347 or HHc2:066522) while others exhibit some degree
of variation in the GFP-expressing territories among founders.
This phenomenon could be due to position effects –i.e. the
regulatory influence exerted by regulatory regions in the vicinity of
the transgene’s insertion point. However, we cannot exclude that
this variability in expression patterns is attributable to some special
properties of these sequences.
The identification of functional CREs is a first step in the
investigation of the gene regulatory networks controlling gene
expression. Here, we have used information based on binding site
composition and gene transcription to identify a number of
potential meis1 trans-regulators. We have followed different
approaches in order to filter out false positives predicted by
bioinformatics. Thus, we considered only those transcription
factors with the top-scoring PWMs and whose expression
overlapped the enhancers’ activity at the stages analyzed.
Interestingly, some candidates with previously described interac-
tion with meis1 were found, such as PBXs or Pax6 genes. To date,
Pax6 has been shown to be directly regulated by Meis genes
during the development of the eye lens and pancreatic islet cells in
the mouse [2,19]. However, a reciprocal regulation of Pax6 on
meis1 has not been described in vertebrates. Under this scenario,
we investigated the regulatory relationship between Pax6 genes
and the meis1 retinal and optic tectum enhancer HHc2:066650 in
zebrafish. Both morpholino analyses, site-directed mutagenesis of
HHc2:066650 and in vivo binding assays led us to conclude that
Pax6 directly regulates HHc2:066650. In addition we show that
zebrafish orthologous HHc2:066650 sequence physically interacts
with the meis1 promoter in its natural genomic context, which
confirms that this HCNR is indeed a meis1 regulatory sequence.
The fact that we do not detect alterations in meis1 expression
pattern or levels by in situ hybridization in pax6 morphants suggests
that its transcriptional regulation is strongly buffered, perhaps by
other CREs with similar enhancer activity, and that the individual
contribution of HHc2:066650 is minor. Due to the large impact of
Pax6 during normal retinal and brain development, it is of great
relevance to identify its downstream targets. Our results suggest
that meis1 should also be considered a direct Pax6 target gene in
vertebrates.
Supporting Information
Figure S1 Human MEIS1 gene lies in a syntenic region
among vertebrates. A) Graphical representation of the MEIS1
regulatory block found according to ECR genome browser which
uses MIME algorithm. B) Detailed correspondence between the
Hg18 region of interest and their orthologous genomic regions
from mouse (mm9), chicken (galga3), frog (xentro), and zebrafish
(danrer05).
(TIF)
Figure S2 GFP-expressing domains displayed by the
different founders. Summary of the expression patterns from
the different founders from all positive cis-regulatory regions found
in the study. Whenever a particular founder exhibit GFP
expression in a defined territory, we refer it as a ‘‘1’’ and the
cell is highlighted in green. When no GFP expression is found, the
corresponding cell remains grey. Forebrain refers to the
presumptive olfactory bulb. M/H_bound. stands for Midbrain-
Hindbrain boundary, and D.R. ganglia stands for Dorsal Root
ganglia.
(TIF)
Figure S3 Morpholinos against Pax6a and Pax6b affect
eye development. Representative pictures of 48 hpf wild type
zebrafish embryos after different MO injection. The microphthal-
mia observed among morphants (red arrow) confirmed the
functionality of the morpholinos. No effects on control morpholino
injected animals were detected.
(TIF)
Figure S4 Effect of Pax6 MOs on the GFP retinal
expression levels of HHc2:066650 stable transgenic line.
Whisker plots showing retinal GFP fluorescence was measured in
both morphants and controls (n = 13 for controls, n = 8 for
MOpaxA; n = 11 for MOpaxB and n = 13 for MOpaxA+B). * : p-
value#0.05 after Mann Whitney test.
(TIF)
Figure S5 Chromatin immunoprecipitation of a myc-
tagged version of Pax6 shows an enrichment in
zHHc2:066650 relative abundance. Levels of zebrafish
HHc2:066650, amplified by PCR, in the chromatin immuopre-
cipitated with an anti-Myc antibody (ChIP) or in the input
chromatin (Input), from 24 hpf embryos injected with 100 pg of a
pax6-myc capped mRNA. The figure represents the average and
the error bars the standard deviation of three independent
analyses.
(TIFF)
Table S1 Transcription factors hits predicted to bind
each human MEIS1 enhancer according to JASPAR
dataset scoring within the first quartile.
(DOC)
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